Aspen Group And Credit Suisse Group On The List Of Winners And Losers Of Monday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Aspen Group, Acer Therapeutics, and Addex Therapeutics Ltd.

Rank Financial Asset Price Change Updated (EST)
1 Aspen Group (ASPU) 0.12 22.78% 2023-03-20 12:46:48
2 Acer Therapeutics (ACER) 0.82 21.67% 2023-03-20 10:43:19
3 Addex Therapeutics Ltd (ADXN) 1.25 13.64% 2023-03-20 11:23:18
4 First Citizens BancShares (FCNCA) 562.29 10.46% 2023-03-20 14:57:50
5 U.S. Gold Corp (USAU) 4.73 9.49% 2023-03-20 14:51:13
6 Aesthetic Medical International Holdings Group Ltd. (AIH) 1.17 8.33% 2023-03-20 13:15:07
7 Momo (MOMO) 8.52 7.65% 2023-03-20 14:43:00
8 Zions Bancorporation N.A. (ZION) 32.14 7.35% 2023-03-20 09:12:07
9 NRG Energy (NRG) 33.67 6.94% 2023-03-20 14:48:22
10 FleetCor Technologies (FLT) 199.17 6.39% 2023-03-20 14:55:04

The three biggest losers today are Credit Suisse Group, FIRST REPUBLIC BANK, and AGBA Acquisition Limited.

Rank Financial Asset Price Change Updated (EST)
1 Credit Suisse Group (CS) 0.94 -53.01% 2023-03-20 14:53:54
2 FIRST REPUBLIC BANK (FRC) 12.10 -47.44% 2023-03-20 14:55:18
3 AGBA Acquisition Limited (AGBAW) 0.03 -38.85% 2023-03-20 13:08:08
4 Pinduoduo (PDD) 79.16 -13.9% 2023-03-20 14:50:01
5 United-Guardian (UG) 9.06 -13.88% 2023-03-19 22:42:16
6 Acutus Medical (AFIB) 0.81 -12.53% 2023-03-20 11:48:19
7 VerifyMe (VRME) 1.53 -11.56% 2023-03-20 14:24:46
8 Senmiao Technology Limited (AIHS) 0.90 -10.89% 2023-03-20 13:17:08
9 UMB Financial Corporation (UMBF) 58.27 -10.74% 2023-03-19 22:55:32
10 Akari Therapeutics Plc (AKTX) 0.23 -10.68% 2023-03-20 15:06:08

Winners today

1. Aspen Group (ASPU) – 22.78%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group rising 22.78% to $0.12 on Monday, after four consecutive sessions in a row of losses. NASDAQ rose 0.39% to $11,675.54, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.383.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.28%.

Volume

Today’s last reported volume for Aspen Group is 7592370 which is 1393.47% above its average volume of 508372.

Revenue Growth

Year-on-year quarterly revenue growth declined by 9.9%, now sitting on 74.29M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aspen Group’s stock is considered to be overbought (>=80).

Moving Average

Aspen Group’s worth is way below its 50-day moving average of $0.24 and way under its 200-day moving average of $0.56.

More news about Aspen Group.

2. Acer Therapeutics (ACER) – 21.67%

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was founded in 1991 and is headquartered in Newton, Massachusetts.

NASDAQ ended the session with Acer Therapeutics rising 21.67% to $0.82 on Monday while NASDAQ rose 0.39% to $11,675.54.

Earnings Per Share

As for profitability, Acer Therapeutics has a trailing twelve months EPS of $-2.058.

Yearly Top and Bottom Value

Acer Therapeutics’s stock is valued at $0.82 at 17:32 EST, way below its 52-week high of $4.56 and way above its 52-week low of $0.65.

More news about Acer Therapeutics.

3. Addex Therapeutics Ltd (ADXN) – 13.64%

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. to develop mGluR2PAM compounds for the treatment of human health; and research collaboration agreement with Indivior PLC. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

NASDAQ ended the session with Addex Therapeutics Ltd rising 13.64% to $1.25 on Monday, following the last session’s downward trend. NASDAQ jumped 0.39% to $11,675.54, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Addex Therapeutics Ltd has a trailing twelve months EPS of $-2.658.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -202.67%.

Yearly Top and Bottom Value

Addex Therapeutics Ltd’s stock is valued at $1.25 at 17:32 EST, way below its 52-week high of $5.45 and way above its 52-week low of $0.55.

Revenue Growth

Year-on-year quarterly revenue growth declined by 45.1%, now sitting on 1.25M for the twelve trailing months.

Moving Average

Addex Therapeutics Ltd’s worth is below its 50-day moving average of $1.32 and above its 200-day moving average of $1.20.

More news about Addex Therapeutics Ltd.

4. First Citizens BancShares (FCNCA) – 10.46%

First Citizens BancShares, Inc. operates as the holding company for First-Citizens Bank & Trust Company that provides retail and commercial banking services to individuals, businesses, and professionals. The company's deposit products include checking, savings, money market, and time deposit accounts. Its loan product portfolio comprises commercial construction and land development, commercial mortgage, commercial and industrial, and lease financing loans, as well as small business administration paycheck protection program loans; and consumer loans, such as residential and revolving mortgage, construction and land development, consumer auto, and other consumer loans. The company also offers treasury services products, cardholder and merchant services, wealth management services, and various other products and services; investment products, including annuities, discount brokerage services, and third-party mutual funds, as well as investment management and advisory services; and defined benefit and defined contribution, insurance, private banking, trust, fiduciary, philanthropy, and special asset services. The company provides its products and services through its branch network, as well as through digital banking, telephone banking, and various ATM networks. As of December 31, 2021, it operated 529 branches in Arizona, California, Colorado, Florida, Georgia, Kansas, Maryland, Missouri, North Carolina, New Mexico, Oklahoma, Oregon, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin, and West Virginia. First Citizens BancShares, Inc. was founded in 1898 and is headquartered in Raleigh, North Carolina.

NASDAQ ended the session with First Citizens BancShares rising 10.46% to $562.29 on Monday while NASDAQ jumped 0.39% to $11,675.54.

Earnings Per Share

As for profitability, First Citizens BancShares has a trailing twelve months EPS of $56.93.

PE Ratio

First Citizens BancShares has a trailing twelve months price to earnings ratio of 9.88. Meaning, the purchaser of the share is investing $9.88 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.25%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Feb 26, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 0.39%.

Volume

Today’s last reported volume for First Citizens BancShares is 375577 which is 256.37% above its average volume of 105388.

More news about First Citizens BancShares.

5. U.S. Gold Corp (USAU) – 9.49%

U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 650 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 87 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project that consists of 103 unpatented mining claims covering approximately 3 square miles in Eureka County, Nevada. The company is based in Elko, Nevada.

NASDAQ ended the session with U.S. Gold Corp jumping 9.49% to $4.73 on Monday while NASDAQ jumped 0.39% to $11,675.54.

Earnings Per Share

As for profitability, U.S. Gold Corp has a trailing twelve months EPS of $-4.367.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.57%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, U.S. Gold Corp’s stock is considered to be oversold (<=20).

More news about U.S. Gold Corp.

6. Aesthetic Medical International Holdings Group Ltd. (AIH) – 8.33%

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 28 treatment centers in China, Hong Kong, and Singapore. The company was founded in 1997 and is headquartered in Shenzhen, China.

NASDAQ ended the session with Aesthetic Medical International Holdings Group Ltd. jumping 8.33% to $1.17 on Monday while NASDAQ jumped 0.39% to $11,675.54.

Earnings Per Share

As for profitability, Aesthetic Medical International Holdings Group Ltd. has a trailing twelve months EPS of $-3.14.

Sales Growth

Aesthetic Medical International Holdings Group Ltd.’s sales growth is 120.3% for the current quarter and 23% for the next.

Volume

Today’s last reported volume for Aesthetic Medical International Holdings Group Ltd. is 2227 which is 71.3% below its average volume of 7761.

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.3%, now sitting on 549.24M for the twelve trailing months.

Yearly Top and Bottom Value

Aesthetic Medical International Holdings Group Ltd.’s stock is valued at $1.17 at 17:32 EST, way below its 52-week high of $2.56 and way higher than its 52-week low of $1.04.

More news about Aesthetic Medical International Holdings Group Ltd..

7. Momo (MOMO) – 7.65%

Hello Group Inc. provides mobile-based social and entertainment services in the People's Republic of China. It operates Momo platform that includes its Momo mobile application, as well as various related properties, features, functionalities, tools, and services. The company's Momo mobile application connects people and facilitates interactions based on location and interests; and various recreational activities, including live talent shows, short videos, and social games, as well as other video- and audio-based interactive experiences, such as online parties, mobile karaoke, and user participated reality shows. It also operates Tantan, a social and dating application, which enables users to find and establish romantic connections, and meet interesting people; and provides live video, quick chat, value-added, mobile marketing, and other services, as well as mobile games and audio chatrooms. In addition, it allows its platform's users to livestream a variety of content and activities that comprise talent shows, such as singing, dancing, and talk shows, as well as casual chatting, and other forms of interactions between broadcasters and viewers. The company was formerly known as Momo Inc. and changed its name to Hello Group Inc. in August 2021. Hello Group Inc. was incorporated in 2011 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Momo jumping 7.65% to $8.52 on Monday while NASDAQ rose 0.39% to $11,675.54.

Earnings Per Share

As for profitability, Momo has a trailing twelve months EPS of $1.49.

PE Ratio

Momo has a trailing twelve months price to earnings ratio of 5.71. Meaning, the purchaser of the share is investing $5.71 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.97%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Momo’s stock is considered to be overbought (>=80).

More news about Momo.

8. Zions Bancorporation N.A. (ZION) – 7.35%

Zions Bancorporation, National Association provides various banking and related services primarily in the states of Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. The company offers corporate banking services; commercial banking, including a focus on small- and medium-sized businesses; commercial real estate banking services; municipal and public finance services; retail banking, including residential mortgages; trust services; wealth management and private client banking services; and capital markets products and services. As of December 31, 2020, it operated 422 branches, which included 273 owned and 149 leased. The company was formerly known as ZB, National Association and changed its name to Zions Bancorporation, National Association in September 2018. Zions Bancorporation, National Association was founded in 1873 and is headquartered in Salt Lake City, Utah.

NASDAQ ended the session with Zions Bancorporation N.A. jumping 7.35% to $32.14 on Monday, following the last session’s downward trend. NASDAQ rose 0.39% to $11,675.54, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Zions Bancorporation N.A. has a trailing twelve months EPS of $5.4.

PE Ratio

Zions Bancorporation N.A. has a trailing twelve months price to earnings ratio of 5.95. Meaning, the purchaser of the share is investing $5.95 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.68%.

Yearly Top and Bottom Value

Zions Bancorporation N.A.’s stock is valued at $32.14 at 17:32 EST, way under its 52-week high of $71.25 and way above its 52-week low of $22.55.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 26% and 22.5%, respectively.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Feb 14, 2023, the estimated forward annual dividend rate is 1.64 and the estimated forward annual dividend yield is 5.11%.

More news about Zions Bancorporation N.A..

9. NRG Energy (NRG) – 6.94%

NRG Energy, Inc., together with its subsidiaries, operates as an integrated power company in the United States. It operates through Texas, East, and West. The company is involved in the producing, selling, and delivering electricity and related products and services to approximately 6 million residential, commercial, industrial, and wholesale customers. It generates electricity using natural gas, coal, oil, solar, nuclear, and battery storage. The company also provides system power, distributed generation, renewable products, backup generation, storage and distributed solar, demand response, and energy efficiency, and advisory services, as well as carbon management and specialty services; and on-site energy solutions. In addition, it trades in electric power, natural gas, and related commodities; environmental products; weather products; and financial products, including forwards, futures, options, and swaps. Further, the company procures fuels; provides transportation services; and directly sells energy, services, and products and services to retail customers under the NRG, Reliant, Direct Energy, Green Mountain Energy, Stream, and XOOM Energy. As of December 31, 2021, it owns and leases power generation portfolio with approximately 18,000 megawatts of capacity at 25 plants. NRG Energy, Inc. was founded in 1989 and is headquartered in Houston, Texas.

NYSE ended the session with NRG Energy jumping 6.94% to $33.67 on Monday while NYSE jumped 1.22% to $14,777.70.

: NRG energy stock charges higher to pace S&P 500 gainers after bofa turns bullishShares of NRG Energy Inc. shot up 6.0% in afternoon trading Monday, enough to pace the S&P 500’s advancers after BofA Securities turned bullish on the fossil and nuclear fuel production company, citing valuation in the wake of the closing of the has lost 5.5% and the S&P 500 has declined 11.6%.

Earnings Per Share

As for profitability, NRG Energy has a trailing twelve months EPS of $2.07.

PE Ratio

NRG Energy has a trailing twelve months price to earnings ratio of 16.26. Meaning, the purchaser of the share is investing $16.26 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.03%.

Yearly Top and Bottom Value

NRG Energy’s stock is valued at $33.67 at 17:32 EST, way under its 52-week high of $47.82 and way higher than its 52-week low of $30.25.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jan 30, 2023, the estimated forward annual dividend rate is 1.51 and the estimated forward annual dividend yield is 4.34%.

More news about NRG Energy.

10. FleetCor Technologies (FLT) – 6.39%

FLEETCOR Technologies, Inc. provides digital payment solutions for businesses to control purchases and make payments. It offers corporate payments solutions, such as accounts payable automation; Virtual Card, which provides a single-use card number for a specific amount usable within a defined timeframe; Cross-Border that is used by its customers to pay international vendors, foreign office and personnel expenses, capital expenditures, and profit repatriation and dividends; and purchasing cards and travel and entertainment cards for its customers to analyze and manage their corporate spending. The company also provides employee expense management solutions, including fuel solutions to businesses and government entities that operate vehicle fleets, as well as to oil and leasing companies, and fuel marketers; lodging solutions to businesses that have employees who travel overnight for work purposes, as well as to airlines and cruise lines to accommodate traveling crews and stranded passengers; and electronic toll payments solutions to businesses and consumers in the form of radio frequency identification tags affixed to vehicles' windshields. In addition, it offers gift card program management and processing services in plastic and digital forms that include card design, production and packaging, delivery and fulfillment, card and account management, transaction processing, promotion development and management, website design and hosting, program analytics, and card distribution channel management. Further, it provides other products consisting of payroll cards, vehicle maintenance service solution, long-haul transportation solution, prepaid food vouchers or cards, and prepaid transportation cards and vouchers. The company serves business, merchant, consumer, and payment network customers in North America, Brazil, and Internationally. The company was founded in 1986 and is headquartered in Atlanta, Georgia.

NYSE ended the session with FleetCor Technologies jumping 6.39% to $199.17 on Monday, after two sequential sessions in a row of losses. NYSE jumped 1.22% to $14,777.70, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, FleetCor Technologies has a trailing twelve months EPS of $8.12.

PE Ratio

FleetCor Technologies has a trailing twelve months price to earnings ratio of 24.53. Meaning, the purchaser of the share is investing $24.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.32%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FleetCor Technologies’s stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 4.1% and 1.7%, respectively.

More news about FleetCor Technologies.

Losers Today

1. Credit Suisse Group (CS) – -53.01%

Credit Suisse Group AG, together with its subsidiaries, provides various financial services in Switzerland, Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company offers wealth management solutions, including investment advice and discretionary asset management services; risk management solutions, such as managed investment products; and wealth planning, succession planning, and trust services. It also provides financing and lending solutions, including consumer credit and real estate mortgage lending, real asset lending relating to ship, and aviation financing for UHNWI; standard and structured hedging, and lombard lending solutions, as well as collateral trading services; and investment banking solutions, such as global securities sales, trading and execution, capital raising, and advisory services. In addition, the company offers banking solutions, such as payments, accounts, debit and credit cards, and product bundles; asset management products; equity and debt underwriting, and advisory services; cash equities, equity derivatives, and convertibles, as well as prime services; and fixed income products, such as credit, securitized, macro, emerging markets, financing, structured credit, and other products. Further, it provides HOLT, a framework for assessing the performance of approximately 20,000 companies; and equity and fixed income research services. The company serves private and institutional clients; ultra-high-net-worth individuals, high-net-worth individuals, and affluent and retail clients; corporate clients, small and medium-sized enterprises, external asset managers, financial institutions, and commodity traders; and pension funds, hedge funds, governments, foundations and endowments, corporations, entrepreneurs, private individuals, financial sponsors, and sovereign clients. As of December 31, 2021, it operated through a network of 311 offices and branches. The company was founded in 1856 and is based in Zurich, Switzerland.

NYSE ended the session with Credit Suisse Group dropping 53.01% to $0.94 on Monday, after five successive sessions in a row of losses. NYSE jumped 1.22% to $14,777.70, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Credit Suisse Group has a trailing twelve months EPS of $0.49.

PE Ratio

Credit Suisse Group has a trailing twelve months price to earnings ratio of 1.93. Meaning, the purchaser of the share is investing $1.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.09%.

More news about Credit Suisse Group.

2. FIRST REPUBLIC BANK (FRC) – -47.44%

First Republic Bank, together with its subsidiaries, provides private banking, private business banking, and private wealth management services to clients in metropolitan areas in the United States. It operates in two segments, Commercial Banking and Wealth Management. The company accepts deposit products, such as noninterest-bearing checking, interest-bearing checking, money market checking accounts, money market savings accounts, and passbook accounts, as well as certificates of deposit. It also offers a range of lending products that comprise residential mortgage loans, home equity lines of credit, multifamily loans, commercial real estate and construction loans, personal and business loans, single family construction loans, and other loans and lines of credit to businesses and individuals. The company's loans are secured by single family residences, multifamily buildings, and commercial real estate properties. In addition, it provides wealth management services, which include various investment strategies and products, online investment management, trust and custody, full service and online brokerage, financial and estate planning, and access to alternative investments, as well as investing, insurance, and foreign exchange services. Further, the company offers online and mobile banking services; refinancing services; and ATM and debit cards. As of December 31, 2021, it offered its services through 82 licensed deposit taking offices primarily in the San Francisco, Palo Alto, Los Angeles, Santa Barbara, Newport Beach and San Diego, California; Portland, Oregon; Boston, Massachusetts; Palm Beach, Florida; Greenwich, Connecticut; New York, New York; and Jackson, Wyoming. It also has 12 additional offices that offer lending, wealth management, or trust services. First Republic Bank was founded in 1985 and is headquartered in San Francisco, California.

NYSE ended the session with FIRST REPUBLIC BANK falling 47.44% to $12.10 on Monday, after two successive sessions in a row of losses. NYSE rose 1.22% to $14,777.70, following the last session’s downward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, FIRST REPUBLIC BANK has a trailing twelve months EPS of $6.4.

PE Ratio

FIRST REPUBLIC BANK has a trailing twelve months price to earnings ratio of 1.89. Meaning, the purchaser of the share is investing $1.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.99%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 29.5% and a negative 34.7%, respectively.

Volume

Today’s last reported volume for FIRST REPUBLIC BANK is 178749000 which is 1179.17% above its average volume of 13973800.

Yearly Top and Bottom Value

FIRST REPUBLIC BANK’s stock is valued at $12.10 at 17:32 EST, way under its 52-week low of $45.00.

More news about FIRST REPUBLIC BANK.

3. AGBA Acquisition Limited (AGBAW) – -38.85%

AGBA Group Holding Limited focuses on operating a full-service platform to banks, other financial institutions, brokers, and individual financial advisors to advise and serve its retail clients. The company offers a range of financial products, such as life insurance, pensions, property-casualty insurance, mutual funds, money lending, and real estate agency services. It also operates an health and wealth management platform that offers a range of services and value-added information in health, insurance, investments, and social sharing. The company is based in Wan Chai, Wan Chai.

NASDAQ ended the session with AGBA Acquisition Limited falling 38.85% to $0.03 on Monday while NASDAQ rose 0.39% to $11,675.54.

More news about AGBA Acquisition Limited.

4. Pinduoduo (PDD) – -13.9%

Pinduoduo Inc., through its subsidiaries, operates an e-commerce platform in the People's Republic of China. It operates Pinduoduo, a mobile platform that offers a range of products, including apparel, shoes, bags, mother and childcare products, food and beverages, fresh produce, electronic appliances, furniture and household goods, cosmetics and other personal care items, sports and fitness items, and auto accessories. The company was formerly known as Walnut Street Group Holding Limited and changed its name to Pinduoduo Inc. in July 2018. Pinduoduo Inc. was incorporated in 2015 and is headquartered in Shanghai, the People's Republic of China.

NASDAQ ended the session with Pinduoduo dropping 13.9% to $79.16 on Monday while NASDAQ rose 0.39% to $11,675.54.

Earnings Per Share

As for profitability, Pinduoduo has a trailing twelve months EPS of $-0.93.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.76%.

More news about Pinduoduo.

5. United-Guardian (UG) – -13.88%

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. The company's medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. The company's industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. It also conducts research and development primarily related to the development of cosmetic ingredients. The company markets its products through marketing partners, distributors, and wholesalers. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

NASDAQ ended the session with United-Guardian sliding 13.88% to $9.06 on Monday while NASDAQ jumped 0.39% to $11,675.54.

Earnings Per Share

As for profitability, United-Guardian has a trailing twelve months EPS of $0.72.

PE Ratio

United-Guardian has a trailing twelve months price to earnings ratio of 12.6. Meaning, the purchaser of the share is investing $12.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.71%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 24%, now sitting on 13.6M for the twelve trailing months.

Moving Average

United-Guardian’s worth is way below its 50-day moving average of $11.11 and way under its 200-day moving average of $13.16.

Yearly Top and Bottom Value

United-Guardian’s stock is valued at $9.06 at 17:32 EST, under its 52-week low of $9.06.

More news about United-Guardian.

6. Acutus Medical (AFIB) – -12.53%

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is based in Carlsbad, California.

NASDAQ ended the session with Acutus Medical sliding 12.53% to $0.81 on Monday, following the last session’s downward trend. NASDAQ rose 0.39% to $11,675.54, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Acutus Medical has a trailing twelve months EPS of $-4.039.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -89.82%.

Sales Growth

Acutus Medical’s sales growth is negative 1% for the present quarter and 13.3% for the next.

More news about Acutus Medical.

7. VerifyMe (VRME) – -11.56%

VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners the ability to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, authentication, serialization, and track and trace features for labels, packaging, and products. This segment also offers consumer engagement capabilities, custom printing of tamper evident labels, utilizing visible and invisible variable codes, and images printed with its proprietary inks. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Rochester, New York.

NASDAQ ended the session with VerifyMe sliding 11.56% to $1.53 on Monday, after two sequential sessions in a row of losses. NASDAQ jumped 0.39% to $11,675.54, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, VerifyMe has a trailing twelve months EPS of $-1.483.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.7%.

Volume

Today’s last reported volume for VerifyMe is 22982 which is 32.35% below its average volume of 33974.

Volatility

VerifyMe’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.71%, a positive 0.06%, and a positive 4.35%.

VerifyMe’s highest amplitude of average volatility was 2.99% (last week), 2.95% (last month), and 4.35% (last quarter).

Moving Average

VerifyMe’s value is way under its 50-day moving average of $1.75 and under its 200-day moving average of $1.58.

Sales Growth

VerifyMe’s sales growth is 2547.1% for the ongoing quarter and 3626.7% for the next.

More news about VerifyMe.

8. Senmiao Technology Limited (AIHS) – -10.89%

Senmiao Technology Limited engages in the automobile transaction and related services business in the People's Republic of China. Its services include the facilitation of automobile transaction and financing, connecting ride-hailing drivers to financial institutions to buy, or get financing on the purchase of, cars to be used to provide ride-hailing services. The company is also involved in the sale of automobiles; and provision of auto finance services. Senmiao Technology has strategic cooperation with Gaode Map for utilization in ride sharing initiatives. Senmiao Technology Limited was incorporated in 2017 and is based in Chengdu, the People's Republic of China.

NASDAQ ended the session with Senmiao Technology Limited falling 10.89% to $0.90 on Monday while NASDAQ jumped 0.39% to $11,675.54.

Earnings Per Share

As for profitability, Senmiao Technology Limited has a trailing twelve months EPS of $-1.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -50.8%.

More news about Senmiao Technology Limited.

9. UMB Financial Corporation (UMBF) – -10.74%

UMB Financial Corporation operates as the bank holding company for the UMB Bank that provides various banking and other financial services. The Commercial Banking segment provides commercial loans and credit cards; commercial real estate financing; letters of credit; loan syndication, and consultative services; various business solutions including asset-based lending, accounts receivable financing, mezzanine debt, and minority equity investments; and treasury management services, such as depository services, account reconciliation, cash management tools, accounts payable and receivable solutions, electronic fund transfer and automated payments, controlled disbursements, lockbox services, and remote deposit capture services. The Institutional Banking segment offers fund administration and accounting, investor services and transfer agency, marketing and distribution, custody, alternative investment services, fixed income sales, trading and underwriting, and corporate trust and escrow services, as well as institutional custody services. This segment also provides healthcare payment solutions comprising custodial services for health savings accounts and private label, multipurpose debit cards to insurance carriers, third-party administrators, software companies, employers, and financial institutions. The Personal Banking segment offers deposit accounts, retail credit cards, private banking, installment loans, home equity lines of credit, residential mortgages, and small business loans, as well as internet banking, ATM network, private banking, brokerage and insurance services, and advisory and trust services. It operates through a network of branches and offices in the states of Missouri, Kansas, Colorado, Illinois, Oklahoma, Texas, Arizona, Nebraska, Iowa, Pennsylvania, South Dakota, Indiana, Utah, Minnesota, California, and Wisconsin. UMB Financial Corporation was founded in 1913 and is headquartered in Kansas City, Missouri.

NASDAQ ended the session with UMB Financial Corporation dropping 10.74% to $58.27 on Monday, following the last session’s downward trend. NASDAQ rose 0.39% to $11,675.54, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, UMB Financial Corporation has a trailing twelve months EPS of $8.01.

PE Ratio

UMB Financial Corporation has a trailing twelve months price to earnings ratio of 7.27. Meaning, the purchaser of the share is investing $7.27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.85%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 6.9% and a negative 28.3%, respectively.

Volume

Today’s last reported volume for UMB Financial Corporation is 1703040 which is 449.69% above its average volume of 309818.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 1.43B for the twelve trailing months.

More news about UMB Financial Corporation.

10. Akari Therapeutics Plc (AKTX) – -10.68%

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory diseases that involve complement and leukotriene pathways. Its lead product candidate is nomacopan, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.

NASDAQ ended the session with Akari Therapeutics Plc sliding 10.68% to $0.23 on Monday while NASDAQ rose 0.39% to $11,675.54.

Earnings Per Share

As for profitability, Akari Therapeutics Plc has a trailing twelve months EPS of $-0.35.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -365.06%.

More news about Akari Therapeutics Plc.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *